FSSAI suspends Dior Pharmaceuticals’ food licence over Punjab plant violations
FSSAI has suspended Dior Pharmaceuticals’ food licence after identifying serious GMP, hygiene, safety-management and traceability failures at its Punjab nutraceutical facility. Operations must remain halted until deficiencies are rectified and compliance is restored.
FSSAI suspended Dior Pharmaceuticals’ food licence after finding serious GMP, hygiene, safety-management and traceability failures at its Punjab nutraceutical plant. The company must halt operations until deficiencies are rectified and regulatory compliance is restored.
Why this matters
The suspension follows a recent signal that FSSAI suspended Dior Pharmaceuticals’ nutraceutical manufacturing licence, reinforcing regulatory scrutiny of the company’s production compliance.
Retail-company signals are accelerating, up 312425% quarter over quarter.